McGill University and Moderna to expand collaborations with new projects in Lipid Nanoparticle research

Published: 19 July 2023

McGill University today announced it has signed agreements with ModernaTX, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to support two innovative...

Canadian researchers on promising path towards developing flu treatment using lipid target

Published: 22 May 2019

For most people, the influenza A virus (IAV), commonly known as the flu, is cleared from the body by our own immune system. In some cases, however, the immune response becomes dysregulated and if...

Using laser light to study how epilepsy arises in the healthy brain

Published: 27 March 2019

Scientists at McGill University have developed a new method to study how seizures arise in the healthy brain. Using laser light guided through ultra-thin optic fibers in the brain of rodents, the...

Safe cannabis pain relief without the “high”

Published: 25 October 2018

In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Centre (MUHC) and McGill University have delivered encouraging news for chronic...

No-Nonsense Approach to Genetic Kidney Disease in Children

Published: 4 October 2018

The Research Institute of the McGill University Health Centre’s (RI-MUHC) push to treat a rare genetic disease in children – with a higher percentage found in French Canadians – has received $2...

Preterm birth: The "Nodal" gene under the microscope

Published: 4 September 2018

Preterm birth is a major global public health problem. Every year, 15 million babies are born prematurely and many will suffer from neurodegenerative disorders, including cerebral palsy, learning...

THE GAZETTE: McGill and MUHC given $500,000 for cannabis, cancer research projects

Published: 16 August 2018

The funding will be split between separate projects looking into the properties of cannabidiol and a search for a new treatment of an aggressive brain cancer. Read more


Back to top